MS On Sun PharmaOW, TP Rs 505Cequa Adds On To Its In-market NDA Products Ilumya, Absorica, BromsiteCequa Is Third Product In Its Ophthalmic PortfolioEstimate $40-60 m In Revenues For Cequa Over The Next Couple Of Months#SUNPHARMA